The American biotechnology company asked regulators in the United States to approve the emergency use of its antibody therapy against the coronavirus.
It is the same drug that President Trump was treated with.
Pharmacist Eli Lilly also requested an emergency use permit for its single antibody therapy against the coronavirus.